Paul S. Herendeen
2021 - Valeant Pharmaceuticals International
Compensation breakdown
| Non-Equity Incentive Plan | $1,010,000 |
|---|---|
| Option Awards | $1,050,034 |
| Salary | $707,692 |
| Stock Awards | $4,109,488 |
| Other | $21,635 |
| Total | $6,898,849 |
Herendeen received $4.1M in stock awards, accounting for 60% of the total pay in 2021.
Herendeen also received $1M in non-equity incentive plan, $1.1M in option awards, $707.7K in salary and $21.6K in other compensation.
Rankings
In 2021, Paul S. Herendeen's compensation ranked 1,789th out of 12,415 executives tracked by ExecPay. In other words, Herendeen earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,789 out of 12,415 | 86th |
Division Manufacturing | 664 out of 5,508 | 88th |
Major group Chemicals And Allied Products | 248 out of 2,378 | 90th |
Industry group Drugs | 209 out of 2,099 | 90th |
Industry Pharmaceutical Preparations | 143 out of 1,549 | 91st |
Pay ratio
| Paul S. Herendeen's Pay | $6,898,849 |
|---|---|
| Median Employee's Pay | $44,617 |
| Pay Ratio | 155to 1 |
In 2021, the annual total compensation of Paul S. Herendeen was $6,898,849.
The annual total compensation of the median employee at Valeant Pharmaceuticals International was $44,617.
The ratio of Paul S. Herendeen's pay to the pay of median employee was therefore 155 to one.
Herendeen's colleagues
We found five more compensation records of executives who worked with Paul S. Herendeen at Valeant Pharmaceuticals International in 2021.
2021
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2021
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
2021
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2021
Sam Eldessouky
Valeant Pharmaceuticals International
Chief Financial Officer
2021
Robert Spurr
Valeant Pharmaceuticals International